A New Dry Eye Medication Under Development
Resolvyx Pharmaceuticals announced promising results for patients that suffer from dry eye syndrome during Phase 2 of a new class of anti-inflammatory medications. RX-10045, as it is now called, is a...
View ArticleLACRISERT® – an Option for Patients with Severe Dry Eye Syndrome
We now have LACRISERT® available in the office for the treatment of dry eye syndrome. So far the results have been promising. LACRISERT® is inserted inside your lower lid once or twice a day....
View Article
More Pages to Explore .....